Recurrent Mantle Cell Lymphoma Withdrawn Phase 2 Trials for Fludarabine (DB01073)

Also known as: Mantle Cell Lymphoma Recurrent

IndicationStatusPhase
DBCOND0028615 (Recurrent Mantle Cell Lymphoma)Withdrawn2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01652014Single or Double Donor Umbilical Cord Blood Transplant in Treating Patients With High-Risk Hematologic MalignanciesTreatment